Comment on Kuyper et al.--Atenolol vs nonatenolol β-blockers for the treatment of hypertension: a meta-analysis.
Department of Pharmacy, Zhu Jiang Hospital, Southern Medical University, Guangzhou, China.
Mingxing
M
Li
Department of Pharmacy, Zhu Jiang Hospital, Southern Medical University, Guangzhou, China; Department of Biopharmaceutical, Yulin Normal University, Yulin, China.
Deqi
D
Jiang
Department of Pharmacy, Zhu Jiang Hospital, Southern Medical University, Guangzhou, China.
Shanshan
S
Yu
Department of Pharmacy, Zhu Jiang Hospital, Southern Medical University, Guangzhou, China.
Yan
Y
Wang
Department of Pharmacy, Zhu Jiang Hospital, Southern Medical University, Guangzhou, China. Electronic address: yongwh2005@163.com.
Yong
Y
Wang
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage*; D001262:Atenolol / Q000008:administration & dosage* / Q000009:adverse effects*; D002121:Calcium Channel Blockers / Q000008:administration & dosage*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D020521:Stroke / Q000209:etiology*
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D001262:Atenolol